» Articles » PMID: 33836753

LINC00221 Silencing Prevents the Progression of Hepatocellular Carcinoma Through Let-7a-5p-targeted Inhibition of MMP11

Overview
Journal Cancer Cell Int
Publisher Biomed Central
Date 2021 Apr 10
PMID 33836753
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Microarray profiles of hepatocellular carcinoma (HCC) identified that long intergenic noncoding RNA 00221 (LINC00221) was upregulated. Herein, we aimed to identify the functional significance and underlying mechanisms of LINC00221 in HCC.

Methods And Results: Human HCC samples had increased expression of LINC00221. Effects of LINC00221 on HCC cellular functions were analyzed using gain- and loss-function approaches. LINC00221 knockdown repressed HCC cell growth, migration, and invasion and enhanced their apoptosis. This anti-tumor effect was validated in vivo. Online prediction showed the potential binding relationship between LINC00221 and let-7a-5p, as well as that between let-7a-5p and matrix metalloproteinase 11 (MMP11). The results of luciferase, RNA immunoprecipitation, and RNA pull-down assays identified that LINC00221 interacted with let-7a-5p to increase expression of MMP11. Furthermore, we demonstrated that LINC00221 silencing increased let-7a-5p and inhibited MMP11 expression, thereby delaying the progression of HCC in vitro.

Conclusions: Silencing of LINC00221 could prevent HCC progression via upregulating let-7a-5p and downregulating MMP11. As such, LINC00221 inhibition presents a promising antitumor strategy for the treatment of HCC.

Citing Articles

Cox-Sage: enhancing Cox proportional hazards model with interpretable graph neural networks for cancer prognosis.

Mao R, Wan L, Zhou M, Li D Brief Bioinform. 2025; 26(2).

PMID: 40067266 PMC: 11894944. DOI: 10.1093/bib/bbaf108.


Microproteins encoded by noncanonical ORFs are a major source of tumor-specific antigens in a liver cancer patient meta-cohort.

Camarena M, Theunissen P, Ruiz M, Ruiz-Orera J, Calvo-Serra B, Castelo R Sci Adv. 2024; 10(28):eadn3628.

PMID: 38985879 PMC: 11235171. DOI: 10.1126/sciadv.adn3628.


The multifaceted perspectives on the regulation of lncRNAs in hepatocellular carcinoma ferroptosis: from bench-to-bedside.

Jin X, Huang C, Tian Y Clin Exp Med. 2024; 24(1):146.

PMID: 38960924 PMC: 11222271. DOI: 10.1007/s10238-024-01418-9.


A pyroptosis-related lncRNA-based prognostic index for hepatocellular carcinoma by relative expression orderings.

Tan J, Yu X Transl Cancer Res. 2024; 13(3):1406-1424.

PMID: 38617506 PMC: 11009817. DOI: 10.21037/tcr-23-1804.


Systematic integration of molecular and clinical approaches in HCV-induced hepatocellular carcinoma.

Shabangu C, Su W, Li C, Yu M, Dai C, Huang J J Transl Med. 2024; 22(1):268.

PMID: 38475805 PMC: 10935926. DOI: 10.1186/s12967-024-04925-1.


References
1.
Dali-Youcef N, Hnia K, Blaise S, Messaddeq N, Blanc S, Postic C . Matrix metalloproteinase 11 protects from diabesity and promotes metabolic switch. Sci Rep. 2016; 6:25140. PMC: 4850390. DOI: 10.1038/srep25140. View

2.
Mao T, Fan K, Liu C . Targeting the CXCR4/CXCL12 axis in treating epithelial ovarian cancer. Gene Ther. 2017; 24(10):621-629. DOI: 10.1038/gt.2017.69. View

3.
Guo C, Song W, Sun P, Jin L, Dai H . LncRNA-GAS5 induces PTEN expression through inhibiting miR-103 in endometrial cancer cells. J Biomed Sci. 2015; 22:100. PMC: 4625733. DOI: 10.1186/s12929-015-0213-4. View

4.
Simo-Riudalbas L, Diaz-Lagares A, Gatto S, Gagliardi M, Crujeiras A, Matarazzo M . Genome-Wide DNA Methylation Analysis Identifies Novel Hypomethylated Non-Pericentromeric Genes with Potential Clinical Implications in ICF Syndrome. PLoS One. 2015; 10(7):e0132517. PMC: 4498748. DOI: 10.1371/journal.pone.0132517. View

5.
Yoon J, Abdelmohsen K, Srikantan S, Yang X, Martindale J, De S . LincRNA-p21 suppresses target mRNA translation. Mol Cell. 2012; 47(4):648-55. PMC: 3509343. DOI: 10.1016/j.molcel.2012.06.027. View